Literature DB >> 3086815

Steroid hormone receptors in laryngeal carcinoma.

E Virolainen, P Tuohimaa, K Aitasalo, J Kyttä, R Vanharanta-Hiltunen.   

Abstract

The larynx has long been shown to be a target organ for androgenic steroids in both women and men, and specific androgen receptors have been determined in normal laryngeal mucosa and in laryngeal carcinoma tissue. In this study, samples from 21 primary laryngeal carcinomas, from 4 recurrent laryngeal carcinomas and from 1 cervical metastasis of laryngeal carcinoma were obtained at the time of surgery to assay specific androgen, estrogen, and progesterone receptors. Specific androgen receptors were found in 8 samples (31%). The level of receptors varied from 1.7 femtomoles (fmol) per milligram to 7.3 fmol/mg cytosol protein. Detectable levels of specific estrogen receptors were found in 18 samples (69%) and progesterone receptors in 8 of the 15 samples studied (53%). There was no apparent correspondence with donors' sex, since samples from both females and males contained all kinds of receptors. We know that antiestrogen inhibits the growth of squamous carcinoma cells lines positive for estrogen receptors in vitro and that this effect is reversible with the appropriate hormone. Thus, the relatively high percentage of estrogen and progesterone receptors found in laryngeal carcinoma tissue may open new aspects in the treatment of laryngeal carcinoma with antihormones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086815     DOI: 10.1177/019459988609400419

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy.

Authors:  Maria B Koenigs; Armida Lefranc-Torres; Juliana Bonilla-Velez; Krupal B Patel; D Neil Hayes; Krzysztof Glomski; Paul M Busse; Annie W Chan; John R Clark; Daniel G Deschler; Kevin S Emerick; Rebecca J Hammon; Lori J Wirth; Derrick T Lin; Edmund A Mroz; William C Faquin; James W Rocco
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

2.  [The effect of hormonal agents on the development of chronic laryngitis and tumor disease. Report of two cases].

Authors:  D Kleemann; B Stengel
Journal:  HNO       Date:  2010-03       Impact factor: 1.284

3.  Differential beta-catenin expression between glottic and supraglottic laryngeal carcinoma.

Authors:  Anastasios K Goulioumis; John Varakis; Panos Goumas; Helen Papadaki
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-04-18       Impact factor: 2.503

4.  Expression of hormone receptors in oropharyngeal squamous cell carcinoma.

Authors:  Hesham Mohamed; Katri Aro; Lauri Jouhi; Antti Mäkitie; Satu Remes; Caj Haglund; Timo Atula; Jaana Hagström
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-26       Impact factor: 2.503

5.  Sex hormone receptor levels in laryngeal carcinoma: a comparison between protein and RNA evaluations.

Authors:  Chiara Bianchini; Antonio Pastore; Stefano Pelucchi; Elena Torreggiani; Elisabetta Lambertini; Elena Marchesi; Eros Magri; Claudia Frasson; Patrizia Querzoli; Roberta Piva
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

6.  Androgen receptors in laryngeal carcinoma.

Authors:  I Toral; G Ciliv; B Gürsel; C Ozdem
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

7.  The prognostic significance of estrogen receptor β in head and neck squamous cell carcinoma.

Authors:  Kresimir Grsic; Iva Ledinsky Opacic; Sanda Sitic; Marija Milkovic Perisa; Petar Suton; Bozena Sarcevic
Journal:  Oncol Lett       Date:  2016-09-15       Impact factor: 2.967

8.  Expression pattern of estroprogestinic receptors in sinonasal inverted papilloma.

Authors:  Agostino Serra; Rosario Caltabiano; Giacomo Spinato; Salvatore Gallina; Salvatore Caruso; Venerando Rapisarda; Paola Di Mauro; Veronica Castro; Angelo Conti; Luisa Licciardello; Luigi Maiolino; Salvatore Lanzafame; Salvatore Cocuzza
Journal:  Oncotarget       Date:  2017-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.